# CPDA-1

NDC: 0942-6322
Generic name: Anticoagulant Citrate Phosphate Dextrose Adenine
Labeler / Manufacturer: Fenwal, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20070624

FDA application: BN770420

## Active ingredients

- ADENINE: 17.3 mg/63mL
- ANHYDROUS CITRIC ACID: 188 mg/63mL
- DEXTROSE MONOHYDRATE: 2 g/63mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: 140 mg/63mL
- TRISODIUM CITRATE DIHYDRATE: 1.66 g/63mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0942-6322"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0942-6322
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e41adb4e-06fb-4141-ba55-50b043f3c9da